Publications by authors named "T J Dunlop"

Phosphorylated Tau proteins are promising biomarkers for the diagnosis and prognosis of Alzheimer's disease. This study presents a novel voltametric sensor using a vanadium MXene polydopamine (VPDA) redox active composite and a Tau-441-specific polyaniline molecularly imprinted polymer (PANI MIP) for the sensitive detection of Tau-441 in interstitial fluid (ISF) and plasma. The VPDA/PANI MIP sensor demonstrates a broad detection range of 5 fg/mL to 5 ng/mL (122 aM/L to 122 pM/L) in ISF without the use of redox mediators, with a lower limit of detection (LOD) of 2.

View Article and Find Full Text PDF

Identifying the time of ovulation is an important process for women seeking and avoiding pregnancy. Luteinizing hormone (LH) plays an important role in ovulation, which is very important in the reproductive mechanism. Therefore, detecting the LH level is of great importance in monitoring ovulation.

View Article and Find Full Text PDF

Mesoscopic carbon-based perovskite solar cells (CPSCs) are often cited as a potential frontrunner to perovskite commercialization. Infiltration, the extent to which perovskite fills the mesoporous scaffold, is critical for optimum performance and stability. However, infiltration data are usually presented as qualitative photographic comparisons of samples with extreme infiltration variation.

View Article and Find Full Text PDF

Traditional solutions to estuarine flood risk management have typically involved the implementation of static 'hard' shoreline protection structures, often at the expense of the natural landscape and the societal and ecosystem benefits they provide. In a changing climate, there is an increasing need to restore these estuarine ecosystems, and alternative measures in the form of Nature-based Solutions (NbS) are being considered. Guidance that balances ecology and engineering is required for NbS to establish as self-sustaining ecosystems.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to see if adding a medication called acetazolamide could help patients with high-grade brain tumors reduce their need for another medication, dexamethasone, which can have side effects.
  • 30 patients participated, and they were split into two groups: one received acetazolamide and the other a placebo (which is just a pretend treatment). They checked to see if they could lower the dexamethasone dosage safely.
  • The study ended early because not enough people joined, and it showed that acetazolamide didn’t help lower the dexamethasone dose as hoped.
View Article and Find Full Text PDF